Plasma therapy for COVID-19 patients
Healthcare Radius|May 2020
With Max Healthcare, Saket credited with becoming the first Indian centre to successfully treat a COVID-19 patient with plasma therapy, Group Medical Director, Dr Sandeep Budhiraja, speaks about its effectiveness treatment
Sandeep Budhiraja
Plasma therapy for COVID-19 patients

What is the category of COVID-19 patients that require plasma therapy? Is there any category of patients who cannot undertake it, because of other health complications?

People who have moderate to severe illness are the right candidates for treatment through plasma therapy. Medically, I would say people who have pneumonia with type I respiratory failure and acute respiratory distress syndrome (ARDS) are the category of patients for this treatment. Patients with mild illness do not require plasma therapy and the treatment is futile in patients with very critical illness with multi-organ failure. There are no other medical conditions under which a patient cannot get this treatment.

How effective is the therapy?

Obviously, it is not a magic bullet and not 100% effective. It is one of the good treatment options available because as of now we do not have any definitive treatment for COVID-19. Most of the therapies are either experimental or have some effectiveness. This is one of the promising therapies, however, it is not an established treatment. More studies are needed to confirm its effectiveness but small studies have merged from the US- they are series of 5-patient report or 10-patient report.

In one series of 5-patient report, all 5 patients on ventilator have successfully come out of it and in another 10 series patients, they found the virus clearing happened rapidly after giving plasma treatment. Therefore, reports like these coupled with our first successful case where the patient responded well to the treatment indicate that plasma therapy is potentially effective therapy. However, larger studies need to be conducted to really say how effective it is.

How is the procedure conducted?

This story is from the May 2020 edition of Healthcare Radius.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

This story is from the May 2020 edition of Healthcare Radius.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

MORE STORIES FROM HEALTHCARE RADIUSView All
Entod opens R&D center in Navi Mumbai
Healthcare Radius

Entod opens R&D center in Navi Mumbai

ENTOD Pharmaceuticals inaugurates a new R&D center in Navi Mumbai, focusing on innovative pharmaceutical solutions and global leadership.

time-read
1 min  |
March 2024
DEDICATED ECMO UNITS: A POST-COVID IMPERATIVE
Healthcare Radius

DEDICATED ECMO UNITS: A POST-COVID IMPERATIVE

In the post-Covid world, the necessity of dedicated ECMO units have become paramount for managing critical cases efficiently, says the author.

time-read
3 mins  |
March 2024
HOPE AMIDST HESITATION?
Healthcare Radius

HOPE AMIDST HESITATION?

The Union Finance Minister Nirmala Sitharaman's Budget 2024-25 elicited a mixed response from healthcare sub-segments.

time-read
3 mins  |
March 2024
THE WONDERS OF WEARABLES Discover how wearables can offer a new hope to migraine patients in India.
Healthcare Radius

THE WONDERS OF WEARABLES Discover how wearables can offer a new hope to migraine patients in India.

Digital therapeutics (Dtx) is an emerging concept for therapeutic approaches in healthcare system.

time-read
2 mins  |
March 2024
ONLINE HEALTHCARE CONSULTATIONS: A TRANSFORMATION UNFOLDING
Healthcare Radius

ONLINE HEALTHCARE CONSULTATIONS: A TRANSFORMATION UNFOLDING

Discover how online consultations are transforming India’s healthcare landscape with the use of advanced technologies.

time-read
9 mins  |
March 2024
DRUG-RESISTANT TUBERCULOSIS: A CHALLENGE IN THE LAST LAP?
Healthcare Radius

DRUG-RESISTANT TUBERCULOSIS: A CHALLENGE IN THE LAST LAP?

India aims to eliminate tuberculosis by 2025, but drug-resistant strains pose a formidable challenge. Explore healthcare leaders’ views and potential solution approaches they offer—in this report.

time-read
10+ mins  |
March 2024
Meghalaya Cancer Conclave 2024 discusses cancer care in the state
Healthcare Radius

Meghalaya Cancer Conclave 2024 discusses cancer care in the state

Led by Dr Mazel Ampareen Lyngdoh, conclave focuses on critical cancer care issues.

time-read
1 min  |
March 2024
Woman with atrial septal defect saved at Medica
Healthcare Radius

Woman with atrial septal defect saved at Medica

A middle-aged woman from West Bengal suffering from Atrial Septal Defect ASD) successfully undergoes a complex procedure at Medica Hospital.

time-read
1 min  |
March 2024
Breastfeeding education initiative launched
Healthcare Radius

Breastfeeding education initiative launched

RISHTA 2024: An initiative by BSV and FOGSI to enhance breastfeeding education in India.

time-read
1 min  |
March 2024
5-kg fibroid removed with minimally invasive myomectomy
Healthcare Radius

5-kg fibroid removed with minimally invasive myomectomy

Doctors at Sahyadri Hospitals in Pune removed a 5-kg fibroid from a 35-year-old woman using a minimally invasive myomectomy, typically used in cesarean sections.

time-read
1 min  |
March 2024